TickerWorth Open the interactive valuation →

Is Emerson Electric Co. (EMR) overvalued or undervalued?

Updated Sep 3, 2026 · auto-modeled from live data · educational, not advice

Backup data source — This price comes from our backup market-data feed. Valuations here are built from company filings and are unaffected.

Fair value
$155.03
Market price
$148.98
Upside to fair value
+4.1%
Verdict
4% below fair value

Test the assumptions — move the discount rate

The DCF value below is a real engine result at each WACC (not a re-estimate). Drag to see how sensitive EMR's DCF is to the discount rate.

Market price: $148.98

At a recent price of $148.98, Emerson Electric Co. (EMR) trades 4% below TickerWorth's blended fair value of $155.03 per share — a discounted-cash-flow model cross-checked against peer multiples and asset value — meaning the market currently prices EMR undervalued vs our estimate of what the business is intrinsically worth. Our fair value sits above the market, an implied +4.1% move to close the gap if the business performs in line with our assumptions. This is an educational model, not a price target or a recommendation — the value moves with the inputs, which you can test yourself using the WACC slider below.

One of the lenses behind that blended figure is a discounted-cash-flow model, which on its own values EMR at about $91.89 per share. The rest of this page walks through that DCF — its assumptions, reverse-DCF and discount-rate sensitivity — because it is the auditable anchor of the blend.

The valuation discounts Emerson Electric Co.'s projected free cash flows at a weighted-average cost of capital (WACC) of 9.8%, with a long-run terminal growth rate of 2.5%. About 72% of the enterprise value comes from the terminal value — the portion beyond the explicit forecast window — which is typical for a stable, cash-generative business and a reminder that small changes in the discount rate or terminal growth assumption swing the intrinsic value meaningfully.

Running the DCF in reverse — solving for the growth the current price already assumes — the market is implying roughly 16.3% annual revenue growth for EMR. Our base case instead assumes about 5.5% average growth over the forecast, so the market is pricing in materially faster growth than our base case. The reverse-DCF is a quick sanity check: it reframes 'is this stock cheap?' as 'do I believe the growth the price requires?' rather than arguing over a single point estimate of fair value.

Sensitivity matters more than any single number. Across a reasonable band of discount-rate assumptions, EMR's modeled DCF value ranges from about $65.63 to $144.93 per share. If that range still sits below today's price, the market is optimistic relative to the model across the whole band; if it brackets the price, the stock is roughly fairly valued on our assumptions. Use the interactive slider to see exactly where your own cost-of-capital view lands.

How to read this page: the DCF fair value is what Emerson Electric Co. would be worth if its cash flows grow as modeled and are discounted at the stated WACC. The assumptions table shows every input and its source; the reverse-DCF shows what the market believes; the sensitivity band shows how fragile the answer is. None of this is investment advice — it is a transparent, auditable framework for forming your own view of EMR's intrinsic value. Figures update as new filings and prices come in.

The assumptions behind EMR's DCF

InputValueSource
Base-year revenue$18,636,000,000Live feed — totalRevenue (TTM)
Base EBIT margin26.9%Computed — trailing operatingMargins, held roughly flat
Forecast revenue growth7% → 6% → 6% → 5% → 4%Assumption — TickerWorth's 5-year explicit forecast
Risk-free rate4.8%Live feed — US 10-year Treasury yield (^TNX)
Beta1.24Live feed — yfinance, 5-year monthly beta vs the S&P 500 (clamped to 0.4–2.5)
Terminal growth2.5%Assumption — TickerWorth house default 2.5%, held below WACC
Diluted shares560MLive feed — sharesOutstanding
Market price$148.98Backup price feed · as of 2026-09-03 07:22 UTC

Auto-modeled from live market data because it's frequently searched — this is NOT a hand-researched model. Every growth, margin and capital assumption is an algorithmic ESTIMATE, cached and refreshed periodically. Drag the WACC slider to test how sensitive the value is.

Explore more

Most undervalued stocks (per our valuation) · All valued stocks · Interactive EMR valuation & downloadable model

Educational tool. Every output reflects the assumptions shown — not a prediction and not investment advice. TickerWorth is an educational DCF tool, not a licensed investment adviser. Figures are estimates derived from public filings and market data and can be wrong.